Your browser doesn't support javascript.
loading
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Blay, J Y; Tlemsani, C; Toulmonde, M; Italiano, A; Rios, M; Bompas, E; Valentin, T; Duffaud, F; Le Nail, L R; Watson, S; Firmin, N; Dubray-Longeras, P; Ropars, M; Perrin, C; Hervieu, A; Lebbe, C; Saada-Bouzid, E; Soibinet, P; Fiorenza, F; Bertucci, F; Boudou, P; Vaz, G; Bonvalot, S; Honoré, C; Marec-Berard, P; Minard, V; Cleirec, M; Biau, D; Meeus, P; Babinet, A; Dumaine, V; Carriere, S; Fau, M; Decanter, G; Gouin, F; Ngo, C; Le Loarer, F; Karanian, M; Meurgey, A; Dufresne, A; Brahmi, M; Chemin-Airiau, C; Ducimetiere, F; Penel, N; Le Cesne, A.
Afiliação
  • Blay JY; Centre Léon Bérard & Université Claude Bernard, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
  • Tlemsani C; Hopital Cochin, Paris, France.
  • Toulmonde M; Departement of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Italiano A; Departement of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Rios M; Institut Cancerologie Lorraine, Centre Alexis Vautrin, Nancy, France.
  • Bompas E; Department of Medical Oncology, Institut de Cancerologie Ouest Nantes, France.
  • Valentin T; Institut Claudius Regaud & Institut Universitaire de Cancerologie, Oncopole, Toulouse, France.
  • Duffaud F; La Timone University Hospital, Marseille, France.
  • Le Nail LR; CHU Tours, 37000 Tours, France.
  • Watson S; Dept of Medical Oncology, Institut Curie & INSERM U830, Institut Curie Research Center, Paris, France.
  • Firmin N; Institut de Cancérologie de Montpellier, Montpellier, France.
  • Dubray-Longeras P; Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France.
  • Ropars M; Eugene Marquis Comprehensive Cancer Center, France.
  • Perrin C; CHU, Rennes, France.
  • Hervieu A; Centre George Francois Leclerc, Dijon, France.
  • Lebbe C; Centre Georges François Leclerc, Dijon, France.
  • Saada-Bouzid E; Dermato-Oncology Unit, Saint Louis Hospital, Paris, France.
  • Soibinet P; Centre Antoine-Lacassagne, Nice, France.
  • Fiorenza F; Institut J Godinot Reims, France.
  • Bertucci F; Institut Paoli-Calmettes, Marseille, France.
  • Boudou P; Hopital Cochin, Paris, France.
  • Vaz G; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Bonvalot S; Hopital Cochin, Paris, France.
  • Honoré C; Gustave Roussy Cancer Campus, Villejuif, France.
  • Marec-Berard P; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Minard V; Gustave Roussy Cancer Campus, Villejuif, France.
  • Cleirec M; Dept pédiatrie, CHU Nantes, France. Electronic address: morgane.cleirec@chu-nantes.fr.
  • Biau D; Hopital Cochin, Paris, France.
  • Meeus P; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Babinet A; Hopital Cochin, Paris, France.
  • Dumaine V; Hopital Cochin, Paris, France.
  • Carriere S; Institut de Cancérologie de Montpellier, Montpellier, France.
  • Fau M; Departement of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Decanter G; Univ. Lille, CHU Lille, ULR 2694 - Metrics: Evaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Gouin F; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Ngo C; Departement of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Le Loarer F; Hopital Cochin, Paris, France.
  • Karanian M; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Meurgey A; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Dufresne A; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Brahmi M; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Chemin-Airiau C; Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Ducimetiere F; Centre Léon Bérard & Université Claude Bernard, Lyon, France. Electronic address: francoise.ducimetiere@lyon.unicancer.fr.
  • Penel N; Univ. Lille, CHU Lille, ULR 2694 - Metrics: Evaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Le Cesne A; Institut J Godinot Reims, France.
Eur J Cancer ; 196: 113454, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38008029
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Fibrossarcoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Fibrossarcoma Idioma: En Ano de publicação: 2024 Tipo de documento: Article